BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$113.32
−1.32%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$113.29
From 52W high−24.44%
Volume468075.00
Market cap$5.35B
P/E (TTM)164.2x
P/S (TTM)13.5x
Div yield—
Key dataOct 30, 2026
Open
$113.29
From 52W high
−24.44%
Volume
468075.00
Market cap
$5.35B
ValuationView details →
P/E (Fwd)
133.0x
EV/EBITDA
98.4x
P/E (TTM)
164.2x
RSI (14)
58.0
MomentumView details →
1D Return
−1.32%
YTD Return
+37.28%
Similar companies
Latest newsMore news →
BillionToOne, Inc. announced that it plans to release financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026, and hold a conference call that day.19d agoBillionToOne launched Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, and expanded its Northstar Select panel from 84 to 102 genes.62d ago